| Israel | Turkey | Austria | |
| Umbilical cord stem cell therapy | from $14,500 | from $5,000 | from $7,500 |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
| Therapeutic Apheresis | - | from $1,350 | - |
| Selective Apheresis | - | from $1,550 | - |
| Plasma Exchange | - | from $3,900 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Immunology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunology treatment journey.
Dr. Amos Toren is a pediatric hemato-oncologist at Sheba Medical Center. He served as Director of the Pediatric Hemato-Oncology and Bone Marrow Transplant Division. Dr. Toren holds a PhD in Human Genetics. He specializes in CAR T-cell therapy and bone marrow transplantation for children. Forbes Israel has recognized his expertise in hematology.
Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.
Dr. Pnina Langevich leads the National Center for Rheumatology at Sheba Medical Center. She is a former Vice President of the World Association of Rheumatologists. Forbes Israel has repeatedly named her among the country’s top doctors. Dr. Langevich treats severe cases of lupus, scleroderma, and rheumatoid arthritis.
Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.